www.bayer.com

• equiv: X-UA-Compatible content: IE=edge,chrome=1
• charset: utf-8
• name: description content: At Bayer, innovations in health and agriculture are at the core of what we do. We develop solutions that improve lives and protect the planet.
• name: keywords content: Bayer, products, agriculture, crop, pharma, pharmaceutical, health, career, jobs, sustainability, press, corporate, investor, share, innovation, board, management, supervisory, research, quarterly, reports, annual, Leverkusen
• name: robots content: index, follow
• property: og:url content: https://www.bayer.com/en/homepage
• property: og:title content: Bayer – Global Home
• property: og:description content: At Bayer, innovations in health and agriculture are at the core of what we do. We develop solutions that improve lives and protect the planet.
• property: og:image content: https://www.bayer.com/sites/default/files/styles/1_91_1_aspect_ratio/public/2020-09/Aerial_view_Bayer_group_headquarters_in_Leverkusen_1200.jpg?h=2240b8e9&itok=VkqvXgtu
• name: twitter:card content: summary_large_image
• name: twitter:title content: Bayer – Global Home
• name: twitter:description content: At Bayer, innovations in health and agriculture are at the core of what we do. We develop solutions that improve lives and protect the planet.
• name: twitter:image content: https://www.bayer.com/sites/default/files/styles/1_91_1_aspect_ratio/public/2020-09/Aerial_view_Bayer_group_headquarters_in_Leverkusen_1200.jpg?h=2240b8e9&itok=VkqvXgtu
• name: facebook-domain-verification content: zpbzhbwzrsgmaxqliod0gr4zhosb94
• name: silktide-cms content: kt3kHzc5lichoYmhwlIzMbEPvIWMr3vQ8NAgFUjloOks0xw1dBwzXZBy7JBWgqnwcEMA772CbjQeQTj71HHNJHSv+wln6fJwh6watRg+5hcAyWHUbxO2DQ9NDiIJIrV9bDsYo9xVFRjOwNLPRwGffg==
• name: Generator content: Drupal 11 (https://www.drupal.org)
• name: MobileOptimized content: width
• name: HandheldFriendly content: true
• name: viewport content: width=device-width, initial-scale=1, maximum-scale=2, shrink-to-fit=no
• name: content_type_and_country_context content: global
• name: search-results-description content: At Bayer, innovations in health and agriculture are at the core of what we do. We develop solutions that improve lives and protect the planet.
• name: last-updated-date content: 02/17/2026 - 18:02
• name: format-detection content: telephone=no

• Skip to content
• http://www.bayer.com/en/
• Deutsch (DE)
• Locations
• Contact Us
• Cookie Settings
• About Us
• Our Mission & Strategy
• Dynamic Shared Ownership
• http://www.bayer.com/en/our-contributions
• The Bayer Brand
• Our Code of Conduct
• Diversity and Inclusion at Bayer
• Number of Women in Management Positions
• Team Bayer
• Overview and Tasks
• Bill Anderson
• Wolfgang Nickl
• Stefan Oelrich
• Heike Prinz
• Rodrigo Santos
• Julio Triana
• Offices Held at other Companies
• Compensation
• Members
• Sustainability in the Supervisory board
• Compensation
• Division Leadership
• Bayer Worldwide
• History
• 1863-1881
• 1881-1914
• 1914-1925
• 1925-1945
• 1945-1951
• 1951-1974
• 1974-1988
• 1988-2001
• 2001-2010
• 2010-2022
• 2023 - Present
• Biographies
• The Bayer Cross
• The Corporate Archives
• Procurement
• Our Approach
• Supplier Code of Conduct
• Strategic Sustainability Focus Areas
• Responsible Procurement
• Industry Initiatives
• Conditions of Purchase
• Customs & International Trade Guidelines
• Delivery and Logistics
• Invoicing
• Downloads & Links
• Contact Procurement
• Corporate Compliance
• Information & IT Security
• Data Privacy Information For Specific Processing Activities
• Speak Up Channel
• OVERVIEW
• Health at Bayer
• https://www.bayer.com/en/health
• Pharmaceuticals
• News & Stories
• Inspired By You
• Treatment Areas
• Cardiology
• Heart Attack
• Transthyretin Amyloid Cardiomyopathy
• Thrombosis
• Diagnosing Heart Disease
• Heart Failure
• High Blood Pressure
• Stroke & Atrial Fibrillation
• The Invisible Made Visible
• Hematology
• Oncology
• Gastrointestinal Stromal Tumor
• Breast Cancer
• Kidney Cancer
• Liver Cancer
• Prostate Cancer
• TRK Fusion Cancer
• Thyroid Cancer
• NSCLC
• Chronic Kidney Disease
• Eye Conditions
• Age-related Macular Degeneration
• Diabetic Macular Edema
• Healthy Aging
• Hormonal & Reproductive Health
• Contraception
• Endometriosis
• Heavy Menstrual Bleeding
• Menopause
• Acne Therapy
• Innovation & Technologies
• Trends
• AAV Therapeutics
• Stem cells - The new age of medical research
• Pharmacogenetics
• Biomarkers
• Precision Medicine
• United against Parkinson’s Disease
• Unlocking the Undruggable Space
• Pharmaceuticals Pipeline
• Clinical Trials
• Worldwide Standards
• Ethics in Clinical Trials
• FAQ
• Access to investigational medicines
• Technology
• Artificial Intelligence
• Chemoproteomics
• PROTAC's
• RNA-targeting SMOLs
• Diagnostic Imaging
• Partnering
• Oncology
• Immuno-oncology
• Targeted Alpha Therapy
• Tumor Intrinsic Pathways
• Covalent binding – Vividion
• Cell and Gene Therapy
• Gene Therapy
• Cell Therapy
• Gene Editing
• Sustainability
• Patient Access Charter
• Leadership Perspective
• Strengthening Healthcare Access
• Empowering Women, Globally
• Boosting Family Planning Usage through Digital Channels
• Capacity building: Addressing Root Causes through Partnerships
• Impact at Scale: The Challenge Initiative
• Promoting Awareness: World Contraception Day (WCD) & the Your Life Campaign
• Providing Accessible and Affordable Contraceptives
• Enabling Family Planning in Humanitarian Settings
• Fighting Neglected Tropical Diseases
• Chagas Disease
• Moving Non-Communicable Diseases Care Forward
• Ensuring a Sustainable Product Supply
• Delivering Better Cancer Care
• Patient Organization
• Patient Engagement
• http://www.bayer.com/en/personal-health/better-health-for-all
• Aiding Digestion
• Caring for Skin
• Relieving Pain
• Protecting Heart Health
• Relieving Allergies
• Supporting Nutrition
• Treating Cold and Flu Symptoms
• Products
• Consumer Health Pipeline
• Partnerships
• Trust and Credibility
• Science-Led Self-Care
• Our Commitments
• Creative and Responsible Marketing
• Empowering Personal Health Sustainably
• The Nutrient Gap Initiative
• News & Stories
• Report a side effect
• Medical Counterfeits
• http://www.bayer.com/en/agriculture-overview
• https://www.bayer.com/en/agriculture
• Farmer Voice
• Publications
• Innovation
• Regenerative Agriculture
• Solutions
• Agriculture Biologicals
• Crop Protection
• Weed Management
• Disease Management
• Insect Management
• Seeds & Traits
• Biotechnology
• Genome Editing
• Plant Breeding
• Digital Farming
• Smart Solutions
• Fruits & Vegetables
• Sustainability Targets
• Water Target
• Empowering Smallholder Farmers
• Impact on Smallholder Livelihoods
• Reducing Crop Protection’s Environmental Impact
• Carbon Ventures
• CoverCress
• Our Carbon Zero Commitment
• U.S. Carbon Program
• European Carbon Program
• PRO Carbono Brasil
• GHG Progress Reporting
• Biodiversity
• Restoring Biodiversity
• Natural Resource Conservation
• Water
• Soil Health
• Land Preservation
• The Crop Science Sustainability Progress Report
• Reporting Matters
• Regen Ag in the Field: Bayer ForwardFarming
• Advances in Agriculture
• Farms of the Future
• Agriculture Pipeline
• Collaborations & Open Innovation
• Global LifeHub Network
• Food Security
• Beyond Growing More
• Resilient Food Systems
• Nutrition
• Food Loss & Waste
• Food Chain Partnership
• Products
• Suppliers
• Counterfeits in Agriculture
• Recognize & Avoid Counterfeits
• Bayer´s Role In Combating Counterfeits
• Bayer Safety Seal & Bayer Seal Scan App
• Product Responsibility
• Product Stewardship
• Safe Use Ambassador
• Product Supply
• Transparency
• Crop Protection
• Glyphosate Guide
• What is Glyphosate?
• Safety Record
• The Challenge
• Fighting Back
• Resources & News
• Industry Supported Research
• GMO Crops
• Plant Breeding
• OpenLabs
• News & Stories
• Events
• Bayer Innovation
• Youth Ag Summit
• Podcast
• Contact Us
• Overview
• Product Areas
• Information for Patients
• Beware of Counterfeits
• Report a Side-Effect
• Our Products
• Science, Research & Innovation
• Unleashing the Potential of AI
• Open Innovation and Collaboration
• At a Glance
• Strategy
• Targets
• Impact
• Reporting and Transparency
• Sustainability Reports
• Additional Reports
• Transparency
• Transparency Reporting
• Science Collaborations
• Code of Conduct for Responsible Lobbying
• Commitment
• Collaboration with Healthcare Professionals
• Our Disclosure Obligations
• ESG Investor Engagement and Webinars
• Political Engagement
• ESG Ratings and Rankings
• Environment
• Climate
• Biodiversity
• Water
• Waste and Packaging
• Social
• Employees
• Health and Safety
• Human Rights
• Modern Slavery Act Statement
• Access to our Products
• Corporate Giving & Social Innovation
• Science Education
• Culture of Remembrance
• Bayer Clubs
• Culture
• Bayer and Sports
• Successful Bayer Athletes
• Parasport
• Promotion of New Talent
• Bayer 04 Leverkusen
• Approach to Tax
• Governance
• Bayer Sustainability Council
• Bioethics Council
• UN Global Compact
• Product Stewardship
• Supplier Management
• Corporate Compliance
• Bayer Human Rights Policy
• Responsible Marketing & Sales
• Protection of Biodiversity
• BASE
• Bioethical Principles
• Position on Global Product Strategy
• Position on Responsible Care
• Position on Deforestation and Forest Degradation
• Position on Insect Decline
• Raising the Bar on Crop Protection Safety Standards
• UN Sustainable Development Goals
• Position on Sustainable Beef Production
• Overview
• Latest News
• News & Stories
• Speeches
• Visual Assets
• Events
• Media Events Overview
• Events Archive
• Media Contacts
• Overview
• Investor News
• Ad Hoc
• Events & Presentations
• Events Archive
• Annual Stockholders’ Meeting
• Notice of the Meeting & Agenda
• Countermotions and Proposals for Election
• Stockholder Statements
• Right to speak
• Right of information
• Right to object
• How to Vote
• FAQs
• Voting Results
• ASM-Services & -Downloads
• ASM Archive
• Financial Reports
• Quarterly Statements
• Annual Report
• Bayer AG Financial Statements
• Compensation Reports and Compensation Systems
• Investor Downloads
• Bayer Share Price
• Stock Chart
• Analyst Consensus
• Dividends
• Debt
• Return Calculator
• Voting Rights Announcements
• ADR Program
• Corporate Governance
• Duties and Activities of the Board of Management
• Supervisory Board
• Disclosure of Managers' Transactions
• Control
• Corporate Compliance
• Links & Downloads
• Contact Us
• Career
• Career Areas
• http://www.bayer.com/en/career/our-culture
• Your benefits
• Your health benefits
• http://www.bayer.com/en/career/your-career
• Our people
• Follow your dreams
• I belong here
• How to join us
• IT Career
• Contact us
• https://www.bayer.com/en/bayer-investor-and-media-update
• https://www.bayer.com/en/about-us#pid-000a13755bcc7e6a725bf099f48aa8f1
• Investor Video Call
• Financial News Conference
• Annual Report
• Q4/FY 2025 Investor Video Call
• Financial News Conference for Fiscal 2025
• Capital Markets Day
• https://www.bayer.com/media/en-us/monsanto-announces-roundup-class-settlement-agreement-to-resolve-current-and-future-claims/
• https://www.bayer.com/media/en-us/bayers-asundexian-demonstrated-a-substantial-26-percent-reduction-in-stroke-after-a-non-cardioembolic-ischemic-stroke-or-high-risk-transient-ischemic-attack-with-no-increase-in-isth-major-bleeding-versus-placebo/
• https://www.bayer.com/media/en-us/nubeqa-darolutamide-receives-third-approval-in-china-for-men-with-advanced-prostate-cancer/
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z
• Top
• http://www.bayer.com/products/products-z
• http://www.bayer.com/en/glyphosate-safety
• http://www.bayer.com/en/managing-the-roundup-litigation
• Consumer Health
• Newsletter
• Social Media Channels
• Global Form
• http://www.bayer.com/rss
• Conditions of Use
• Privacy Statement
• Imprint
• Sitemap

• PRO Carbono Argentina
• Stockholders’ Portal
• Job Postings
• Crop Science
• http://www.facebook.com/Bayer
• http://twitter.com/bayer
• http://www.youtube.com/user/BayerTVinternational
• http://www.linkedin.com/company/bayer
• http://instagram.com/bayerofficial

            Domain Name: BAYER.COM
Registrar: CSC Corporate Domains, Inc.
Domain Status: client transfer prohibited
Domain Status: server delete prohibited
Domain Status: server transfer prohibited
Domain Status: server update prohibited
Creation Date: 1996-01-25T05:00:00Z
Registry Expiry Date: 2027-01-26T05:00:00Z
Updated Date: 2025-01-22T06:14:08Z
Name Server: PDNS1.CSCDNS.NET
Name Server: PDNS2.CSCDNS.NET
REGISTRAR Contact: CSC Corporate Domains, Inc.
>>> Last update of RDAP database: 2026-07-13T16:08:00Z         

			#
# robots.txt
#
# This file is to prevent the crawling and indexing of certain parts
# of your site by web crawlers and spiders run by sites like Yahoo!
# and Google. By telling these "robots" where not to go on your site,
# you save bandwidth and server resources.
#
# This file will be ignored unless it is at the root of your host:
# Used:    http://example.com/robots.txt
# Ignored: http://example.com/site/robots.txt
#
# For more information about the robots.txt standard, see:
# http://www.robotstxt.org/robotstxt.html

#User-agent: python-requests/2.20.0
#Disallow: /

User-agent: *
# CSS, JS, Images
Allow: /core/*.css$
Allow: /core/*.css?
Allow: /core/*.js$
Allow: /core/*.js?
Allow: /core/*.gif
Allow: /core/*.jpg
Allow: /core/*.jpeg
Allow: /core/*.png
Allow: /core/*.svg
Allow: /profiles/*.css$
Allow: /profiles/*.css?
Allow: /profiles/*.js$
Allow: /profiles/*.js?
Allow: /profiles/*.gif
Allow: /profiles/*.jpg
Allow: /profiles/*.jpeg
Allow: /profiles/*.png
Allow: /profiles/*.svg
# Directories
Disallow: /core/
Disallow: /profiles/
Disallow: /sites/default/files/notbeindexed/
# Files
Disallow: /README.txt
Disallow: /web.config
# Paths (clean URLs)
Disallow: /admin/
Disallow: /comment/reply/
Disallow: /filter/tips
Disallow: /node/add/
Disallow: /search/
Disallow: /user/register/
Disallow: /user/password/
Disallow: /user/login/
Disallow: /user/logout/
Disallow: /contact/
Disallow: /kontakt/
Disallow: /report/
Disallow: /event/
Disallow: /product/
Disallow: /uk/ua/v-med-news/overview 
Disallow: /uk/ua/v-med-news/1 
Disallow: /uk/ua/v-med-news/mednews231 
Disallow: /uk/ua/v-med-news/anticoagulant-therapy 
Disallow: /uk/ua/v-med-news/endometriom 
Disallow: /uk/ua/v-med-news/dienogest 
Disallow: /uk/ua/v-med-news/contraception 
Disallow: /uk/ua/v-med-news/2 
Disallow: /uk/ua/v-med-news/3 
Disallow: /uk/ua/v-med-news/time-interview
Disallow: /*/locations$
Disallow: /*cl0n3*

# Paths (no clean URLs)
Disallow: /index.php/admin/
Disallow: /index.php/comment/reply/
Disallow: /index.php/filter/tips
Disallow: /index.php/node/add/
Disallow: /index.php/search/
Disallow: /index.php/user/password/
Disallow: /index.php/user/register/
Disallow: /index.php/user/login/
Disallow: /index.php/user/logout/
Disallow: /*?
Disallow: /*?autotranslate=*
Disallow: /en/data-privacy-information-for-managing-contingent-workforce
Disallow: /*/form/*
Disallow: /*/webform/*
Disallow: /en/cxpatients
Disallow: /en/investors/document-download-tool?
Disallow: /de/investoren/document-download-tool?
Disallow: /node/*
Sitemap: https://www.bayer.com/sitemap.xml

#                                    ..::------==------::..                                  
#                              .::-==========================--:.                            
#                          .:-=============-----------============--:.                       
#                      .:-========--::..                ..::---=======-:.                    
#                   .:-=======-:.         -++++++++=-.         .::--=====-:.                 
#                 .-=======-.             =##*+++++###:            .:--=====-:               
#               .-======-.                =##=.....+##=               .:--====-:             
#             .-=====-:                   =###########.                  .:--===-:           
#           .-=====-.                     =##-     :##*                    .:--===-.         
#          :=====-:                       =##*+++++*##-                      .:--===:        
#         -=====:                         :=========-.                         .:--==-       
#       .-=====.                               ...                              .::--=-.     
#      .-====-.                              .####:                               :::-==.    
#      -====-                               .##*+##:                               :::-=-.   
#     -====-                               .##*  +##:                               :::---   
#    :====-.                              .###=---###:                               :::-=-  
#   .=====:                              .############:                              .:::-=. 
#   -====-                              .###.       *##:                              ::::-- 
#   =====:                                                                            .::::-.
#  :=====   -++++++++=-         -++-    .=++.      .+++. :++++++++++=   .++++++++=:    ::::-:
#  -====-   +##++++++###.      =####+    .+##=    -##*.  -##*=======-   .##*====+##*   .::::-
#  -====:   +##-:::::*##.     +##--##=     :##*..*##-    -##+:::::::.   .##+....:###   .::::-
#  -====:   +##########*     =##-  -##=      +####*.     -##########-   .#########*:   .::::-
#  -====:   +##:     -##=   =###****###=      =##+       -##=           .##+..=##*.    .:::::
#  :-===-   +##*+++++###:  =##=======+##=     -##=       -##*+++++++=   .##+   .*##-   .:::::
#  .-====   -=========:   .==-        -==.    .==:       .==========-    ==:     -==:  :::::.
#   :-===:                                 ..........                                 .:::::.
#   ::-==-                                =##########+                                :::::: 
#    :--==:                               =##-........                               .:::::. 
#    ::-==-                               =##*+++++++:                               ::::::  
#     ::-==-                              =##+=======:                              ::::::   
#      ::--=-                             =##=........                             ::::::.   
#       :::-=-                            =##########+                            ::::::.    
#        :::---.                                                                 ::::::.     
#         ::::-=:                         .:::::::::.                          .::::::       
#          .:::---.                       =##########*.                       :::::::        
#            ::::---.                     =##-     =##=                     :::::::.         
#             .:::::--:                   =###****###*.                  .:::::::.           
#               .:::::--:.                =##=---*##+                  .:::::::.             
#                 .:::::::-:.             =##-    =##*.             .::::::::.               
#                    .:::::::::..         -**:     :***:        .::::::::::.                 
#                      .::::::::::::...                   ..::::::::::::.                    
#                          .::::::::::::::::::::::::::::::::::::::::.                        
#                              ..::::::::::::::::::::::::::::::..                            
#                                    ....::::::::::::::....        

Тецхницал СЕО

СЕО на страници

Садржај и кориснички доживљај